Key facts
- This page summarizes Nathaniel Sisitsky's Form 4 filing for STAAR SURGICAL CO (STAA).
- 2 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 18 Mar 2025, 18:03.
Nathaniel Sisitsky - 14 Mar 2025 Form 4 Insider Report for STAAR SURGICAL CO (STAA)
- Reporting relationship
- Chief Legal Officer
- Issuer ticker
- STAA
- Reported as of
- 14 Mar 2025
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 18 Mar 2025, 18:03:09 UTC
- Prior SEC filing
- 14 Mar 2025
- Next SEC filing
- 12 Dec 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Nathaniel Sisitsky
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Nathaniel Sisitsky filed Form 4 for STAAR SURGICAL CO (STAA) on 18 Mar 2025.
Change
- Previous filing in this sequence was filed on 14 Mar 2025.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
STAA
transaction
Derivative
Restricted Stock Units
Award
- Transaction value
- $0
- Shares
- +43,989
- Change %
- Price
- $0.000000
- Shares after
- 43,989
- Date
- 14 Mar 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 43,989
- Exercise price
- $0.000000
- Footnotes
- F1, F2
STAA
transaction
Derivative
Restricted Stock Units
Award
- Transaction value
- $0
- Shares
- +8,798
- Change %
- Price
- $0.000000
- Shares after
- 8,798
- Date
- 14 Mar 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 8,798
- Exercise price
- $0.000000
- Footnotes
- F1, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Each restricted stock unit (RSU) represents the right to receive one share of the Corporation's common stock upon vesting.
Footnote F2
Reflects RSUs granted to the Reporting Person on March 14, 2025 in connection with annual equity award. These RSUs vest as to 1/3 (14,663 shares) on March 14, 2026, 1/3 (14,663 shares) on March 14, 2027, and 1/3 (14,663 shares) on March 14, 2028.
Footnote F3
Reflects RSUs granted to the Reporting Person on March 14, 2025 in connection with the Reporting Person's promotion to Chief Legal Officer. These RSUs vest as to 1/3 (2,932 shares) on March 14, 2026, 1/3 (2,933 shares) on March 14, 2027, and 1/3 (2,933 shares) on March 14, 2028.